Biological Assembly 1  

 3D View: Structure | 1D-3D View | Validation Report

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 10.62 kDa 
• Atom Count: 745 
• Modelled Residue Count: 99 
• Deposited Residue Count: 99 
• Unique protein chains: 1

5O2Q

p130Cas SH3 domain Vinculin peptide chimera

• PDB DOI: 10.2210/pdb5O2Q/pdb
• BMRB: 34143

• Classification: STRUCTURE FROM CYANA 3.97
• Organism(s): Homo sapiens
• Expression System: Escherichia coli
• Mutation(s): No 


• Deposited: 2017-05-22 Released: 2017-09-20 
• Deposition Author(s): Hexnerova, R., Veverka, V.

---

Experimental Data Snapshot

• Method: SOLUTION NMR
• Conformers Calculated: 100 
• Conformers Submitted: 40 
• Selection Criteria: structures with the least restraint violations 

Literature

Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners.

Gemperle, J., Hexnerova, R., Lepsik, M., Tesina, P., Dibus, M., Novotny, M., Brabek, J., Veverka, V., Rosel, D.

(2017) Sci Rep 7: 8057-8057

• PubMed: 28808245 
• DOI: 10.1038/s41598-017-08303-4
• Primary Citation of Related Structures:  
  5O2M, 5O2P, 5O2Q


• PubMed Abstract: 
  

CAS is a docking protein downstream of the proto-oncogene Src with a role in invasion and metastasis of cancer cells. The CAS SH3 domain is indispensable for CAS-mediated signaling, but structural aspects of CAS SH3 ligand binding and regulation are not well understood. Here, we identified the consensus CAS SH3 binding motif and structurally characterized the CAS SH3 domain in complex with ligand. We revealed the requirement for an uncommon centrally localized lysine residue at position +2 of CAS SH3 ligands and two rather dissimilar optional anchoring residues, leucine and arginine, at position +5. We further expanded the knowledge of CAS SH3 ligand binding regulation by manipulating tyrosine 12 phosphorylation and confirmed the negative role of this phosphorylation on CAS SH3 ligand binding. Finally, by exploiting the newly identified binding requirements of the CAS SH3 domain, we predicted and experimentally verified two novel CAS SH3 binding partners, DOK7 and GLIS2.

---

Organizational Affiliation: 

Department of Cell Biology, Faculty of Science, Charles University, Vinicna 7, Prague, Czech Republic. [e-mail].

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Breast cancer anti-estrogen resistance 1,Vinculin	A	99	Homo sapiens	Mutation(s): 0  Gene Names: BCAR1
UniProt & NIH Common Fund Data Resources
Find proteins for P18206 (Homo sapiens) Explore P18206  Go to UniProtKB:  P18206
PHAROS:  P18206
Find proteins for P56945 (Homo sapiens) Explore P56945  Go to UniProtKB:  P56945
PHAROS:  P56945
UniProt Groups	P18206P56945

Experimental Data & Validation

Experimental Data

• Method: SOLUTION NMR
• Conformers Calculated: 100 
• Conformers Submitted: 40 
• Selection Criteria: structures with the least restraint violations 
• OLDERADO: 5O2Q Olderado

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2017-05-22 
• Released Date: 2017-09-20 
Deposition Author(s): Hexnerova, R., Veverka, V.

Revision History  

• Version 1.0: 2017-09-20
  Type: Initial release
  
• Version 1.1: 2019-05-08
  Changes: Data collection
• Version 1.2: 2019-10-30
  Changes: Data collection, Database references